Phase III results: tiotropium* Respimat < sup > ® < /sup > is effective in symptomatic asthma patients irrespective of their allergic status

Phase III results: tiotropium* Respimat < sup > ® < /sup > is effective in symptomatic asthma patients irrespective of their allergic status
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news